#USA #Vienna #Baxter #Hemopatch #hemostat

A New Era in Surgical Innovation: Baxter's HEMOPATCH

In a remarkable gathering of surgical expertise, Baxter Healthcare showcased its innovative HEMOPATCH sealing hemostat during a symposium held in Vienna, Austria. This event not only served as a platform for unveiling the latest advancements in surgical technology but also celebrated over ten years of trust in the HEMOPATCH brand, which has become an integral part of surgeries worldwide, offering critical support and precision in challenging environments.

The newly introduced HEMOPATCH marks a significant milestone with its ambient-temperature collagen pad designed for hemostasis and sealing in both open surgeries and minimally invasive procedures. This cutting-edge hemostat reflects direct insights gathered from daily users, ensuring it meets the real clinical needs faced in operating rooms. The symposium featured expert speakers who shared their invaluable experiences and how these insights contributed to the development of the new HEMOPATCH.

One such expert, General Surgeon Professor Selman Uranüs, was among the first to experience the HEMOPATCH at the event. He noted, “I first used the HEMOPATCH for experimental tests. Since then, it has become part of my daily practice due to its unique sealing properties, especially in laparoscopic surgery. Eliminating the need for refrigeration and extending shelf life are crucial improvements that guarantee its availability in the operating room when it's needed the most.”

A Commitment to Innovation and Collaboration

The symposium not only highlighted the advancements of the HEMOPATCH but also reaffirmed the collaborative efforts between Baxter and the surgical community. The hemostat’s design emphasizes accessibility and practicality directly within operating rooms, showcasing Baxter's unwavering commitment to enhancing surgical care tools. It is a product born from close interaction with surgeons, reflecting their practical needs and expectations.

As the launch of the HEMOPATCH moves forward, further information will be shared on its global availability. In this evolving panorama of healthcare, products like the HEMOPATCH stand at the forefront, promising improved surgical outcomes through innovative solutions.

To learn more about the HEMOPATCH sealing hemostat, interested parties can visit this link for more detailed information.

Regulatory Information

This content is exclusively directed to healthcare professionals and should not be interpreted as medical advice. For any health-related queries, consulting a qualified healthcare professional is recommended. The HEMOPATCH sealing hemostat is approved for use in select countries only. For specific information regarding the regulatory status and availability of the product in your area, contacting a local Baxter Healthcare representative is advised.

Baxter and HEMOPATCH are registered trademarks of Baxter International Inc. or its subsidiaries. This release is part of a wider commitment to ongoing medical innovation and support for the surgical community.